A Real-world Analysis of the Treatment of HER2+ Metastatic Breast Cancer (mBC) Beyond First-line HER2-directed Therapies. Issue 7 (July 2019) - DeSouza, K.; Zammit, R.; Bloomfield, D.; Simcock, R.; Sinha, R.; Westwell, S.; Moss, C.; Moss, A.; Sham, J.; Patel, G.